Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBANDRONATE vs IBUPROFEN LYSINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBANDRONATE vs IBUPROFEN LYSINE: Safety Overview

Metric IBANDRONATE IBUPROFEN LYSINE
Total FAERS Reports 10,178 277
Deaths Reported 236 27
Death Rate 2.3% 9.7%
Hospitalizations 1,420 110
Average Patient Age 69.0 yrs 12.6 yrs
% Female Patients 95.4% 46.1%
FDA Approval Date Apr 30, 2012 Apr 13, 2006
Manufacturer Eugia US LLC Recordati Rare Diseases Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Prescription